Nutritional support for chronic myelogenous and other leukemias: a review of the scientific literature.
Chronic myelogenous leukemia (CML) is a slowly progressive disease characterized by the overproduction of granulocytes (neutrophils, eosinophils, and basophils). A blood smear shows moderate elevations in white blood cell counts that may persist for years and be benign. Platelets are increased in number, although their function is impaired, resulting in symptoms of easy bleeding (purpura, swollen gums). Conventional medical treatment is a marrow transplant and alkylating agents, which are usually prescribed only during crisis. Several nutrients and botanicals have been studied for use in CML, including vitamin A and all-trans retinoic acid (Retin-A), vitamin D3, vitamin E, vitamin B12, indirubin (found in herbs including Indigofera tinctoria and Isatis tinctoria), and Curcuma longa. This article briefly reviews the scientific literature on the therapeutic use of these nutrients for CML.
Steriti
Ronald
R
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D003474:Curcumin / Q000008:administration & dosage; D006801:Humans; D007211:Indoles / Q000008:administration & dosage; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy*; D018529:Nutritional Support / Q000379:methods*; D014212:Tretinoin / Q000008:administration & dosage; D014815:Vitamins / Q000008:administration & dosage*
D000970:Antineoplastic Agents; D007211:Indoles; D014815:Vitamins; D014212:Tretinoin; D003474:Curcumin; C027185:indirubin